Skip to main content
. 2019 May 8;34(4):209–217. doi: 10.1089/cbr.2018.2654

Table 1.

Standard Uptake Value Mean Calculated Before (Baseline Imaging) and After T-DM1 Therapy Using [18F]FDG and [89Zr]pertuzumab Positron Emission Tomography/Computed Tomography

Radiopharmaceutical and group SUV mean baseline imaging SUV mean post therapy imaging
[18F]FDG—control group 3.8 ± 0.9 4.7 ± 3.1
[89Zr]pertuzumab—control group 40.6 ± 7.5 43.2 ± 8.3
[18F]FDG—T-DM1 group 4.0 ± 1.9 3.5 ± 3.4
[89Zr]pertuzumab—T-DM1 group 41.9 ± 2.0 47.5 ± 15.9

SUV, standard uptake value; T-DM1, Ado-trastuzumab emtansine.